BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2005
View Archived Issues
Dopamine transporter ligand identified with potential efficacy as a treatment for cocaine addiction
Read More
Mechanism of action of the antiinflammatory effects of erythromycin in vivo
Read More
NCX-4016 reported to decrease platelet activation in patients with type 2 diabetes
Read More
Good safety profile found for Adenovirus Type-5 HIV vaccines in healthy subjects
Read More
Cytolin decreases viral load and increases T-cell count in HIV-infected patients
Read More
Pharmacopeia and Celgene select compound for development
Read More
3M and Takeda sign agreement for HPV infection and cervical dysplasia
Read More
Helix subsidiary signs agreement with Apotex
Read More
A novel PAR2 agonist induces gastric mucosal cytoprotection
Read More
Second phase I study for MPC-6827
Read More
OSI-930 enters clinical development
Read More
Mechanisms of CB2 cannabinoid receptor antinociception
Read More
Phase II study for antianxiety agent MN-305
Read More
Mechanism of action of the HIV-1 attachment inhibitor, BMS-488043
Read More
Full enrollment reached in phase II MATCHED study of MC-4232
Read More
SP-01A set to enter phase II/III study in Q2
Read More
GenPath becomes AVEO Pharmaceuticals
Read More
OccuLogix cleared to begin crossover studies of RHEO system for dry AMD
Read More
Preclinical activity of a novel nonpeptide selective vasopressin V1A receptor antagonist, YM-218
Read More
Non-approvable letter for Lexapro in panic disorder
Read More
Exubera NDA accepted for filing
Read More
Norpiperidine imidazoazepines: a novel class of selective nonsedative H1 antihistamines
Read More
New opioid receptor antagonists for gastrointestinal dysfunction disclosed by Adolor
Read More
AstraZeneca claims novel Aurora kinase inhibitors for the treatment of cancer
Read More
New cannabinoid CB1 receptor modulators prepared and tested at AstraZeneca
Read More
New treatment for varicose veins described in patent literature
Read More